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Abstract 
Implants have been used as replacement materials for lost tissues and are mainly from metals such as stainless steel and titanium. 
Metals implants may release toxic elements, and alternative such as magnesium-based implants are suggested but its high 
degradation rate in human bio-environment limit its uses. Thus, we proposed alloying the magnesium with zinc atoms and 
dispersing bioactive hydroxyapatite (HAp) within the magnesium and zinc matrix and assess the effects of the conditioned- 
medium from the Mg-Zn-HAP on human bone marrow mesenchymal stem cells (hMSC) viability. The Mg with and without 
Zinc powders were purchased from Merck and Alfa Aesar. The precursor powder has particle size of 0.06-0.3 mm. Powder 
mixtures with different composition i.e., 100 weight percent (wt%) Mg, 9:1 Mg-Zn, 90:9:1 Mg-Zn-Mn, 9:1 Mg-Zn + 10 wt% 
HAp and 90:9:1 Mg-Zn-Mn + 10 wt% HAP were sintered at 300 °C. Then, the powder was incubated with culture medium (1.0 
mg/ml and 2.0 mg/ml) and placed in an incubator shaker for 4 hours. The medium was filtered using 0.2 µm syringe filter and 
kept at 4 °C. The conditioned-medium was supplemented with 10% (v/v) fetal bovine serum and 1% Pen/Strep and incubated 
overnight at 37 °C in a CO2 incubator prior to use on hMSC. The cell viability was assessed using Alamar Blue assays at Days 1, 
2, 4 and 7. The hMSC showed increased proliferation when cultured in MgZn- and MgZnMn-conditioned medium when 
compared to Mg-HAp conditioned medium. These metallic ions may play role in stimulating cell proliferation. The presence of 
metallic ions such as Mg, Mn and Zn promote hMSC proliferation and may play role as an important elements for regeneration 
of hard tissue during implantation. 
© 2016 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of School of Materials and Mineral Resources Engineering, Universiti Sains Malaysia. 
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1. Introduction 
 
Increasing demand for implants has seen the development of bio-implants composite materials incorporating 
various types of compatible materials. For load bearing applications, metal is commonly used which includes 
stainless steels, titanium alloys and cobalt-chromium based alloys1. Nevertheless, corrosion products from these 
alloys may be considered harmful to human tissues. Thus, alternative must be available to ensure safety and benefits 
for patients. Magnesium has growingly gain attention as potential implants for load bearing areas; cheaper option 
and beneficial ionic release to human body. Magnesium (1.7 g/cm3) has almost similar density to human calvarial 
bone (1.75 g/cm3), and an elastic modulus of 45 GPa similar to human bone (40-57 GPa)1. Magnesium is commonly 
present within human bone and muscle, and lacks of it may induce osteoporosis2. Hence, magnesium may influence 
hard tissue mineralization by binding strongly to phosphates through formation of hydroxyapatite1. 
In term of magnesium-based biomaterials, many studies incorporated magnesium within matrices or scaffold 
during fabrication, since magnesium is known as an important cofactor for broad number of enzymes such as 
transferase, oxidoreductase and isomerase. Ions present within the biomaterials such as magnesium (Mg), zinc (Zn), 
calcium (Ca), manganese (Mn), strontium (Sr) and cobalt (Co) are important in bone regeneration and essential 
cofactors of enzyme, collectively known as metallic ions for therapeutic application (MITA)3. Magnesium alloys, on 
the other hand, may have a few issues if it used solely as implant materials such as corrosion products from these 
alloys, timing of corrosion process upon implantation and also its effects to the surrounding tissue. 
Although magnesium alloys has gained acceptance for its light weight properties, however, the corrosion 
behavior need proper understanding prior to the use of magnesium as potential implant for load bearing areas. 
Magnesium alloys may undergo many types of corrosion process such as galvanic and intergranular corrosion4. To 
harness magnesium alloys for biomedical applications, a few elements such earth metal alkali and alkaloids can be 
incorporated within the structure of magnesium alloys to enhance its properties. Strontium (Sr), zinc (Zn), 
manganese (Mn) and calcium (Ca) have been used previously to reduce the corrosion effects and slows down 
biodegradation1. Other element such as copper (Cu) and aluminum (Al) has been used as alloying elements in Mg. 
However, excessive copper amounts have been linked to neurodegenerative diseases like Alzheimer‘s and in high 
doses of aluminum has been shown to increase estrogen-related gene expression in human breast cancer cell when 
cultured in a laboratory setting5. 
In the current work, we propose alloying the magnesium with zinc atoms and dispersing bioactive hydroxyapatite 
(HAp) in the Mg-Zn alloy matrix by mechanical alloying forming a Mg-Zn-HAp composite. First, Zn atoms are 
added to the Mg through mechanical alloying mechanism in ball and mill setting. Then HAP powder is added to the 
Mg-Zn matrix. Problems within the Mg-Zn-HAp composite may exist such as inhomogeneous dispersion of each 
particles and presence of globules within the matrix. Different phases in HAp dispersed Mg-Zn composite would 
provide different corrosion mechanism in body fluid. For example, high level of Zn can dramatically increase the 
corrosion rate as a result of the formation of intermetallic particles in comparison to low level of Zn. At the same 
time, dispersed HAp particles would provide different corrosion rate as it is the noblest phase amongst the Mg alloy 
and Mg-Zn intermetallic phases. 
Since the composite is multi-phase, the objectives of this work are to propose mechanical alloying mechanism of 
magnesium and zinc, to investigate interfacial bonding of the composite and to study compatibility of the composite 
with human bones from the aspect of mechanical integrity and biodegradation rate. However, in this part of the 
paper, we reported the dissolution properties of Mg-Zn-HAp composite powder in cell culture medium and then 
used the medium on human mesenchymal stem cells (hMSCs) viability. We hypothesized that addition of other 
elements such as Zn, Mn and HAp within the Mg may reduce the degradation rate and the presence of HAp may 
enhance osseointegration. Currently, novel strategies based on biodegradable metals, such as magnesium alloys and 
iron, which are dissolved in vivo when no longer needed have potential in bone regeneration6. 
 
 
2. Materials and Method 
 
2.1 Synthesis of Mg-Zn alloys 
 M.N. Siti Noor Fazliah et al. /  Procedia Chemistry  19 ( 2016 )  75 – 82 77
 
Mixture of Mg-Zn elemental powder and pure HAp powder at different ratio (Table 1) was prepared and 
mechanically milled in order to synthesize Mg-Zn based alloy with a specific range of ball to powder ratio (BPR of 
10:1), milling speed of 200 rpm and was milled for 2 hours. 
 
Table 1. The samples prepared based on weight ratio 
 
Samples Weight ratio (%) Weight (grams) HAP (weight percent, wt%) 
Mg 100 20 g - 
MgZn 90:10 Mg (18 g), Zn (2 g) - 
MgZnMn 90:9:1 Mg (18 g), Zn (1.8 g), Mn (0.2 g) - 
MgZnHAp 90:10 Mg (16.2 g), Zn (1.8 g) 10 (2 g) 
MgZnMnHAp 90:9:1 Mg (16.2 g), Zn (1.62 g), Mn (0.18 g) 10 (2 g) 
 
 
2.2 Dispersing HAp within the Mg-Zn matrix 
 
The HAp powder was dispersed into the Mg-Zn matrix through a second step mechanical milling and 
compaction of Mg-Zn-HAp powder mixture using uniaxial single pressing (400 MPa) technique for consolidation of 
the powder. Then, the Mg-Zn-HAp powder is sintered in a tube furnace (300 °C, 1 hour) under inert Argon gas for 
powder densification. The powder is then sent for particle size analysis (Malvern Instruments, UK). 
 
2.3 Conditioned medium preparation 
 
The powder as prepared above (Mg, MgZn, MgZnMn, MgZnHAp and MgZnMnHAp) was weighted accordingly 
at a ratio of 1.0 mg/ml and β.0 mg/ml and incubated with Dulbecco‘s εodified Eagle‘s εedium (DεEε, Gibco, 
USA) culture medium for 4 hours and placed in an incubator shaker at 37 °C. At the end of the incubation, the 
media was filtered using a syringe filter (0.22 µm) at kept at 4 °C until further used. 
 
2.4 Elemental analysis of conditioned medium 
 
In order to assess the amount of ions released from the Mg and Mg alloys powder, the culture media collected 
was filtered (0.β ȝm syringe filter) and samples containing dissolution ions from εg and εg alloys powder were 
diluted by a factor of 10 in deionised (DI) water. The elemental concentrations of the following ions: magnesium 
(Mg), zinc (Zn), manganese (Mn), calcium (Ca) and phosphorus (P) ions were analysed by inductively coupled 
plasma – optical emission spectrometer (ICP-OES). The standard curve of each ion was prepared according to the 
manufacturer‘s instructions to ensure that the amount of ions released is within the normal range and each sample 
was read in triplicates. 
 
2.5 Cell viability using alamarBlue® assay 
 
One of the assays available to assess cell viability is the alamarBlue® (AB) (Invitrogen, Gibco, USA) assay 
which functions as a cell health indicator. Living cells maintain a reducing environment within the cytosol of the 
cell, and they are able to convert resazurin (blue, non-fluorescent), the active ingredient of AB reagent, to resofurin 
(red fluorescence) once the dye entered the cells. Viable cells continuously convert resazurin to resofurin which 
causes an increase in the overall fluorescence and colour of the media surrounding cells. The amount of fluorescence 
produced is used as a quantitative indicator of cell viability since it is proportional to the number of living cells. The 
alamarBlue® (AB) assay was performed following instructions from the manufacturer. Once the human 
mesenchymal stem cells (hMSC) reached 90% confluent, the cells were trypsinized and counted using 
haemocytometer followed by seeding in 96-well plates (5×103 cells/cm2). The cells were treated with Mg-based 
conditioned media and incubated in a CO2 incubator at 37 °C with 5 % CO2. At designated time points (1, 2, 4 and 7 
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days), the cell-culture media were taken out from the well plates followed by washing steps using 100 ȝl of DPBS. 
Approximately, 1η0 ȝl of 10 % (v/v) alamarBlue® in DMEM with no phenol red (Gibco, USA) was added per well 
(including one with no cells to be used as blank) and the well plates were further incubated for 2 hours at 37 ºC. 
Following the β hours incubation period, 100 ȝl of the reaction product was then transferred to a black Costar 96- 
well plate. The fluorescence of AB was read with an excitation wavelength of 544 nm and emission at 590 nm using 
a microplate reader (FluoStar Omega, BMG). 
 
 
3. Results and Discussion 
 
3.1 Properties of Mg-Zn alloys 
 
The precursor powder size range was from 60 to 300 µm. The resultant powder obtained is shown in Table 2. As, 
expected there is a tendency for the particle size to increase upon combination of the precursor powders during the 
fabrication of Mg-Zn-HAp composites. Although, for futures use as implantable materials, the composites will be 
prepared in bulk such as rods or pellets, it is important to assess the initial effect of these composites using powders 
in vitro. This is also part of the requirement prior to commercialization of the product. The bigger particle size may 
have influence on the ion dissolution properties7. 
 
Table 2. The particle size of the Mg-Zn-HAp powder 
 
Samples D10 (µm) D50 (µm) D90 (µm) 
Mg 103.91 209.94 381.59 
MgZn 129.37 258.43 495.34 
MgZnMn 147.56 279.46 560.41 
MgZnHAp 121.39 247.94 430.88 
MgZnMnHAp 88.37 230.37 416.12 
Hap 1.03 6.28 14.19 
 
3.2 Ion studies release from the Mg-Zn-HAp composite 
 
The concentration of magnesium (Mg), zinc (Zn), manganese (Mn), calcium (Ca) and phosphorus (P) is shown in 
Fig. 1, respectively. In describing metal upon immersion in simulated body fluids, the term corrosion is commonly 
used. However, in this paper, we used the term ion dissolution to explain the concentration of ion being released out 
from the particle or powder upon immersion in simulated body fluids; once the powder is immersed in the solution, 
ion will leach out and there is a possibility for the particle size to be reduced in size. As particle size has an effect on 
the rate of dissolution, we would expect that bigger particle may have a lower dissolution rate due to lower surface 
area. 
The magnesium ion which dissolute from the particle showed that as the powder to liquid ratio increased (from 1 
mg/ml to 2 mg/ml), the concentration increases with sample containing magnesium powder only (Mg1.0 and Mg2.0) 
showed the highest concentration compared to the other powder samples. The zinc dissolutions after four hours were 
low in all samples ranging from 0.11 µl/mg (MgZn1.0) up to 0.36 µl/mg (MgZnMnHAP2.0). For the manganese, 
only MgZnMnHAp samples showed approximately 0.04 µg/ml concentration of ion dissolution into the culture 
medium. 
The hydroxyapatite (HAp) incorporation into the Mg-Zn matrix is hoped to enhance osseointegration of Mg- 
alloy based implants with host tissue. Hydroxylapatite materials have been widely used as implantable materials8. 
Most implantable materials used previously were single-phase, and addition of other elements into the implants was 
commonly performed on commercial products in order to reduce the toxic effects of by-products and minimize 
corrosion process9. Our ICP-OES results showed that for calcium and phosphorus ion dissolutions when the powder 
to liquid ratio was increased from 1.0 mg/ml to 2.0 mg/ml, the ion dissolutions into the culture medium decreased. 
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This may be due to the continued HA formation on the surface which retards further ion dissolution. However, the 
calcium and phosphorus concentration dissolution into the culture medium from our study was low. For calcium, the 
dissolution in all samples ranging from 23.07 µl/mg (MgZn2.0) up to 25.67 µl/mg (MgZnMnHAP2.0). While for 
phosphorus, the concentration range was from 12.1 µl/mg (MgZn2.0) up to 13.33 µl/mg (MgZnMnHAP2.0). These 
values were low compared to calcium concentration where approximately 80-100 ppm of calcium is needed for 
initiation of bone mineralization10, 11. 
 
 
 
Fig. 1: Ionic dissolution profiles of Mg based biomaterials following 4 hours incubation. 
 
 
 
The magnesium and zinc released from the powder will be elaborated further, using the 1.0 mg/ml as the 
reference and is shown in Fig. 2 respectively. During fabrication of the magnesium alloy, similar magnesium weight 
was incorporated for sample MgZn and MgZnMn (18 g, Table 1). However, the concentration of magnesium 
released from the powder into the culture medium are different from both sample where 34.74 µg/ml Mg was 
released from MgZn and 45.87 µg/ml Mg was released from MgZnMn. The same trend was also observed for zinc 
in MgZnMn and MgZnHAp samples where similar zinc amount in weight (1.8 g) for MgZnMn and MgZnHAp was 
incorporated during fabrication. However, the concentrations of zinc released from both are different. This may be 
explained by the fact that the amount of magnesium and zinc incorporated during the fabrication is less than it 
should be when the value is converted into mole percentages. In fabricating implant materials, the end result is the 
whole bulk of the composite where the components are merged together during sintering which will produced a 
homogenous product. For example, during fabrication of MgZn, incorporation of magnesium (molecular weight, 
MW=24.31 g/mol) and zinc (MW=65.38 g/mol) will result in MgZn (MW=89.69 g/mol). Upon conversion of the 
magnesium and zinc into mole percentages (mol%), a lower concentration of magnesium and zinc is present within 
the MgZn composite (Table 3). Accurate amount of any ions or elements incorporation during fabrication of 
biomaterials for biomedical applications is crucial since the release profile or dissolution of these ions in vivo will 
affect many cell metabolism and signaling pathways12. In the current study, the magnesium dissolution into the 
media for example for the MgZn1.0 composite (1 mg/ml powder to liquid ratio) was approximately 34.74 µg/ml 
where as for the MgZn2.0 composite (2 mg/ml powder to liquid ratio) approximately 50.57 µg/ml Mg had dissolute 
out into the media. These values are considered safe for cell culture studies as shown by the AB assay results where 
cell remain viable until Day 7 (Fig. 3). Zhang et al13 showed that bioceramics silicate powder containing strontium- 
magnesium (Sr-Mg-Si) dissolved with cell culture medium up to 200 mg/ml did not negatively affect human bone 
marrow mesenchymal stem cells (BMSCs) and showed enhance alkaline phosphatase activity of the BMSCs 
suggesting that  the  elements contained within the  composite  (Sr, Mg, Si) may promote mineralization. This 
hypothesis  may  promote  discussion  and  challenges  during  fabrication  of  magnesium  alloys  for  biomedical 
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application and warrant further investigations. When these elements are incorporated within a scaffold or matrices, 
the effect might be slightly less as compared when used as bulk materials. 
 
 
 
 
  
 
 
 
 
 
Fig. 2: Ionic dissolution profiles of Mg, Zn and Mn following 4 hours incubation. 
 
 
Table 3. The relative molecular mass of the magnesium and magnesium composite samples 
 
Element RMM 
Weight 
Mg (g) 
Mole% 
Mg 
Weight 
Zn (g) 
Mole% 
Zn 
Weight 
Mn (g) 
Mole% 
Mn 
Weight 
HAP (g) 
Mole% 
HAP 
Total weight 
(g) 
Mg 24.31 20.00 82.29 0.00 0.00 0.00 0.00 0 0.00 20.00 
MgZn 89.69 18.00 20.07 2.00 2.23 0.00 0.00 0 0.00 20.00 
MgZnMn 144.62 18.00 12.45 1.80 1.24 0.20 0.14 0 0.00 20.00 
MgZnHAp 592.00 16.20 2.74 1.80 0.30 0.00 0.00 2 0.34 20.00 
MgZnMnHAp 646.93 16.20 2.50 1.62 0.25 0.18 0.03 2 0.31 20.00 
 
3.3 hMSCs response to Mg-conditioned medium 
 
The human mesenchymal stem cells (hMSC) responded favorably to the magnesium-conditioned medium (Fig. 3 
and 4). There was an increase of cell viability from days 1 to 7 in all samples. At day 1, cells seeded in MgZnMn- 
conditioned medium showed the highest viability compared to cells exposed to other samples although no 
significance differences were observed (One-way ANOVA, Scheffe post-hoc). At days 4 and 7, cells seeded in 
MgZnMn-conditioned medium (2 mg/ml) showed the highest viability compared to other groups (Fig. 3). In general, 
the presence of magnesium within the composites promote cell viability and proliferation especially for hMSC 
exposed to MgZnMn-conditioned. This may be explained by the presence of all three elements which is magnesium, 
zinc  and  manganese  that  is  important  in  stimulation  of  new  bone  tissue  and  adhesion  of  osteoblast  cells3. 
Magnesium is vital for living cells (interact with phosphate ions), stimulation of new bone tissue and adhesion of 
osteoblast cells. Zinc among other role is associated with growth hormone and insulin like growth factor, stimulate 
bone formation through enhanced osteoblast differentiation, and able to act as an anti-inflammatory agent. While, 
manganese is an important cofactor for many enzymes3, 6 
 
 
 
 
 
 
 
 
 
 
Fig. 3: hMSC showed increased proliferation when exposed to Mg-conditioned medium (Mg, MgZn, MgZnMn) when compared to Mg-HAP 
conditioned medium (MgZnHAp, MgZnMnHAp) at days 1 to 7. 
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Fig. 4: There was increased in hMSC cell number during exposure to Mg-conditioned medium from days 2 to 7 indicating suitability of these 
composites for biomedical applications.
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In this preliminary work, we have shown that the addition of elements such as zinc and manganese into the 
magnesium matrix enhanced hMSC viability. The concentration of each ions dissolution into the culture medium is 
lower than expected, which may be due to the lower amount of the initial elements added since the initial calculation 
was based on weight percent. Future work should look into a few issues such as assessing the effect of higher 
concentration of powder to medium ratio in vitro (to determine toxic dose to cells), adjusting the Mg-alloys 
composition based on mole percentage in relation to the bulk or Mg-alloy composites (to be used as implantable 
material), assessing the effect of bulk Mg-based biomaterials such as pellet or disc in vitro (to assess ion release or 
corrosive properties on cells) and determining the ionic dissolution profiles from bulk type over a certain period of 
time (to reflect implantation in tissue or organ). In conclusion, magnesium alloy and magnesium-based biomaterials 
have potential to be used as implantable materials due to the safe ionic dissolution release profile which may 
promote bone cells viability and thus enhancing mineralization. 
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